Rx Redefined Inc.

Based in the US, Rx Redefined Inc. specializes in Durable Medical Equipment management, offering streamlined supply and delivery solutions through a patented platform that enhances compliance and efficiency in healthcare processes. Rx Redefined Inc. operates as a provider of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) management.

Founded by Brandon Boots and Erik Smith, the company is headquartered in Arroyo Grande, California, US. In August 2022, Rx Redefined raised USD 8. 00 mn in a Series A funding round, led by Crosscut Ventures and included contributions from Hatteras Venture Partners, Silverton Partners, and Tusk Venture Partners. This funding represents the total amount the company has raised to date, which is USD 8.

00 mn. Rx Redefined specializes in full-service management of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), focusing on physician-led ordering processes. The core services include in-office product supply and delivery, facilitated by a patented platform that ensures compliance with DMEPOS regulations and medical billing requirements. The services primarily benefit physicians and their patients, enabling them to select medical products autonomously, while adhering to regulatory standards.

The company operates across various geographical markets in the United States, aiming to improve patient care through efficient supply management and strong customer support. Rx Redefined generates revenue through management services related to DMEPOS, primarily operating on a B2B basis. Healthcare providers partner with Rx Redefined to utilize its platform for processing patient orders. Each transaction involves physician orders processed through the company's application, ensuring regulatory compliance.

The pricing structure reflects the value of comprehensive services provided, including audit processing and adherence documentation, supported by a proprietary management platform that integrates with existing Electronic Medical Record (EMR) systems. In August 2022, Rx Redefined raised USD 8. 00 mn in Series A funding. The company plans to utilize this funding to extend the features of its product, enhance productivity, and accelerate sales efforts.

While specific upcoming product launches have not been detailed, Rx Redefined is targeting expansion into new markets to broaden its geographic reach. The company aims to implement these growth strategies in the near future, leveraging recent investments to support its initiatives.